Amabile-Cuevas, C., Cardenas-Garcia, M., Ludgar, M. 1995. Antibiotic Resistance. American Scientist. 83(4)320-329.

Biednenbach, D., Jones, R. 1997. Disk diffusion test interpretive criteria and quality control recommendations for testing linezolid (U-100766) and eperezolid (U-100592) with commercially prepared reagents. Journal of Clinical Microbiology. 35(12):3198-202.

Hancock, R., Lehrer, R. 1998. Journal of Antimicrobial Chemotherapy 41(6):589-603.

Hare, R. 1970. The Birth of Penicillin and the Disarming of Microbes. George Allen and Unwin, London. Fascinating account of the discovery of penicillin.

Levy, S. 1998. The Challenge of Antibiotic Resistance, Scientific American 278(3):46-53.

Mandell, G., Bennett, J., Dolin, R. (ed) 2000. Principles and Practice of Infectious Diseases, 5^th ed. Churchill Livingston.

Moolenaar, R., Pasley-Shaw, R., Harkess, J., Lee, A., Crutcher, J. 2000. High Prevalence of Penicillin-Nonsusceptible Streptococcus pneumoniae at a Community Hospital in Oklahoma. Emerging Infectious Diseases. 6(3)283-289.

Murray, P., Baron, E., Tenover, F., Yolken R., (ed.). 1999. Manual of clinical microbiology, 7th ed. American Society for Microbiology, Washington, D.C.

Rolinson, G. 1998. Forty years of beta-lactam research. Journal of Antimicrobial Chemotherapy 41(6):589-603.

Thomson, C. 1999. The global epidemiology of resistance to ciprofloxacin and the changing nature of antibiotic resistance: a 10 year perspective. Journal of Antimicrobial Chemotherapy. 43 Suppl A:31-40.

Walsh, C. 1999. Deconstructing vancomycin. Science 284(5413)442-443.

Winquist, A., Fukuda, K., Bridges, C., Cox, N. 1999. Neuraminidase Inhibitors for Treatment of Influenza A and B Infections. Morbidity Mortality Weekly Report 48(RR14)1-9.